Terms: = Pancreatic cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
571 results:
1. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer.
Raymant M; Astuti Y; Alvaro-Espinosa L; Green D; Quaranta V; Bellomo G; Glenn M; Chandran-Gorner V; Palmer DH; Halloran C; Ghaneh P; Henderson NC; Morton JP; Valiente M; Mielgo A; Schmid MC
Nat Commun; 2024 Apr; 15(1):3593. PubMed ID: 38678021
[TBL] [Abstract] [Full Text] [Related]
2. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via stat3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract] [Full Text] [Related]
3. stat3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.
D'Amico S; Kirillov V; Petrenko O; Reich NC
Elife; 2024 Apr; 13():. PubMed ID: 38573819
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-associated macrophages drive glycolysis through the IL-8/stat3/GLUT3 signaling pathway in pancreatic cancer progression.
Zhong Z; Yang K; Li Y; Zhou S; Yao H; Zhao Y; Huang Y; Zou J; Li Y; Jiajia Li ; Lian G; Huang K; Chen S
Cancer Lett; 2024 Apr; 588():216784. PubMed ID: 38458594
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/stat3 signaling.
Xie S; Li X; Yan J; Yu H; Chen S; Chen K
Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977
[TBL] [Abstract] [Full Text] [Related]
6. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
7. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/stat3 pathway.
Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
[TBL] [Abstract] [Full Text] [Related]
8. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract] [Full Text] [Related]
9. A bibliometric and visual analysis of cancer-associated fibroblasts.
Yuan WC; Zhang JX; Chen HB; Yuan Y; Zhuang YP; Zhou HL; Li MH; Qiu WL; Zhou HG
Front Immunol; 2023; 14():1323115. PubMed ID: 38173726
[TBL] [Abstract] [Full Text] [Related]
10. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pstat3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract] [Full Text] [Related]
11. cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and pancreatic cancer Initiation Via LAMA5/ITGA4 Axis.
Parte S; Kaur AB; Nimmakayala RK; Ogunleye AO; Chirravuri R; Vengoji R; Leon F; Nallasamy P; Rauth S; Alsafwani ZW; Lele S; Cox JL; Bhat I; Singh S; Batra SK; Ponnusamy MP
Gastroenterology; 2024 May; 166(5):842-858.e5. PubMed ID: 38154529
[TBL] [Abstract] [Full Text] [Related]
12. Dynamic IL-6R/stat3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells.
Blaszczak W; White B; Monterisi S; Swietach P
Cell Rep; 2024 Jan; 43(1):113612. PubMed ID: 38141171
[TBL] [Abstract] [Full Text] [Related]
13. IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.
Li XH; Huang GZ; Xu ZL; Zhao CY; Dong XY; Cui BK; Lin XJ
J Transl Med; 2023 Dec; 21(1):911. PubMed ID: 38098005
[TBL] [Abstract] [Full Text] [Related]
14. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Afaq F; Agarwal S; Bajpai P; Diffalha SA; Kim HG; Peter S; Khushman M; Chauhan SC; Mukherjee P; Varambally S; Manne U
Neoplasia; 2024 Jan; 47():100951. PubMed ID: 38039923
[TBL] [Abstract] [Full Text] [Related]
15. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
[TBL] [Abstract] [Full Text] [Related]
16. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and stat3 interplay.
Vitali E; Valente G; Panzardi A; Laffi A; Zerbi A; Uccella S; Mazziotti G; Lania A
J Endocrinol Invest; 2024 May; 47(5):1101-1117. PubMed ID: 37882947
[TBL] [Abstract] [Full Text] [Related]
19. NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via stat3-IFIT3 axis.
Hu H; Li B; Chen H; Fan G; Ye Z; Ji S; Yu X; Xu X; Qin Y
Mol Carcinog; 2024 Feb; 63(2):195-208. PubMed ID: 37846815
[TBL] [Abstract] [Full Text] [Related]
20. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
[TBL] [Abstract] [Full Text] [Related]
[Next]
